company background image
NVRO

Nevro NYSE:NVRO Stock Report

Last Price

US$36.68

Market Cap

US$1.3b

7D

-3.3%

1Y

-40.6%

Updated

27 Jan, 2023

Data

Company Financials +

NVRO Stock Overview

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally.

NVRO fundamental analysis
Snowflake Score
Valuation2/6
Future Growth1/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

New

Notes are coming soon

Nevro Corp. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Nevro
Historical stock prices
Current Share PriceUS$36.68
52 Week HighUS$78.90
52 Week LowUS$34.70
Beta0.82
1 Month Change-5.97%
3 Month Change-5.56%
1 Year Change-40.59%
3 Year Change-72.40%
5 Year Change-53.87%
Change since IPO45.61%

Recent News & Updates

Does Nevro (NYSE:NVRO) Have A Healthy Balance Sheet?

Jan 13
Does Nevro (NYSE:NVRO) Have A Healthy Balance Sheet?

Nevro: Opportunity Overshadowed By Weaknesses

Dec 07

Recent updates

Does Nevro (NYSE:NVRO) Have A Healthy Balance Sheet?

Jan 13
Does Nevro (NYSE:NVRO) Have A Healthy Balance Sheet?

Is Nevro (NYSE:NVRO) Weighed On By Its Debt Load?

Oct 02
Is Nevro (NYSE:NVRO) Weighed On By Its Debt Load?

Is Nevro (NYSE:NVRO) Weighed On By Its Debt Load?

Jun 17
Is Nevro (NYSE:NVRO) Weighed On By Its Debt Load?

Nevro (NYSE:NVRO) Has Debt But No Earnings; Should You Worry?

Feb 07
Nevro (NYSE:NVRO) Has Debt But No Earnings; Should You Worry?

Is Nevro (NYSE:NVRO) Using Too Much Debt?

Aug 03
Is Nevro (NYSE:NVRO) Using Too Much Debt?

Nevro Corp.'s (NYSE:NVRO) Shift From Loss To Profit

May 07
Nevro Corp.'s (NYSE:NVRO) Shift From Loss To Profit

Nevro (NYSE:NVRO) Has Debt But No Earnings; Should You Worry?

Apr 17
Nevro (NYSE:NVRO) Has Debt But No Earnings; Should You Worry?

Have Insiders Been Selling Nevro Corp. (NYSE:NVRO) Shares?

Mar 16
Have Insiders Been Selling Nevro Corp. (NYSE:NVRO) Shares?

Introducing Nevro (NYSE:NVRO), The Stock That Zoomed 271% In The Last Five Years

Feb 09
Introducing Nevro (NYSE:NVRO), The Stock That Zoomed 271% In The Last Five Years

Should You Investigate Nevro Corp. (NYSE:NVRO) At US$180?

Jan 22
Should You Investigate Nevro Corp. (NYSE:NVRO) At US$180?

Is Nevro (NYSE:NVRO) Using Debt Sensibly?

Jan 04
Is Nevro (NYSE:NVRO) Using Debt Sensibly?

Shareholder Returns

NVROUS Medical EquipmentUS Market
7D-3.3%-0.1%2.3%
1Y-40.6%-9.6%-9.7%

Return vs Industry: NVRO underperformed the US Medical Equipment industry which returned -9.6% over the past year.

Return vs Market: NVRO underperformed the US Market which returned -9.7% over the past year.

Price Volatility

Is NVRO's price volatile compared to industry and market?
NVRO volatility
NVRO Average Weekly Movement8.4%
Medical Equipment Industry Average Movement8.8%
Market Average Movement6.9%
10% most volatile stocks in US Market17.3%
10% least volatile stocks in US Market2.9%

Stable Share Price: NVRO is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: NVRO's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2006945D. Grossmanhttps://www.nevro.com

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence.

Nevro Corp. Fundamentals Summary

How do Nevro's earnings and revenue compare to its market cap?
NVRO fundamental statistics
Market CapUS$1.29b
Earnings (TTM)-US$7.94m
Revenue (TTM)US$395.28m

3.3x

P/S Ratio

-163.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
NVRO income statement (TTM)
RevenueUS$395.28m
Cost of RevenueUS$125.02m
Gross ProfitUS$270.26m
Other ExpensesUS$278.20m
Earnings-US$7.94m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

Feb 16, 2023

Earnings per share (EPS)-0.22
Gross Margin68.37%
Net Profit Margin-2.01%
Debt/Equity Ratio57.4%

How did NVRO perform over the long term?

See historical performance and comparison